Company Showcase Participants

The listing below shows the participants in the Early or Later Stage Showcase sessions, in date/time order.

Early Stage Showcase - Advanced Therapies
Tuesday, 9th May - 13:30 to 15:30
Chaired By:
Companies:

  • 13:30 - 13:40
    Apceth Biopharma, Christine Guenther, CEO/CMO/QP (Germany)

Early Stage Showcase - Biotech Therapeutics
Tuesday, 9th May - 13:30 to 15:30
Chaired By:
Companies:

  • 13:30 - 13:40
    Mironid, Neil Wilkie, COO (United Kingdom)
  • 13:40 - 13:50
    Sareum, Tim Mitchell, CEO (United Kingdom)
  • 13:50 - 14:00
    Cypralis Ltd, Simon Kerr, CEO (United Kingdom)
  • 14:00 - 14:10
    Auspherix, Neil Miller, CEO (United Kingdom)
  • 14:10 - 14:20
    Selvita S.A., Wojciech Czardybon, R&D Consulting Director (Poland)
  • 14:20 - 14:30
    Arecor Ltd, Sarah Howell, CEO (United Kingdom)
  • 14:30 - 14:40
    Elasmogen Ltd, Caroline Barelle, CEO (United Kingdon)
  • 14:40 - 14:50
    Chronos Therapeutics , Huw Jones , CEO (United Kingdon)
  • 14:50 - 15:00
    Avacta, Alastair Smith, CEO (United Kingdon)
  • 15:00 - 15:10
    Osivax, Alexandre le Vert, CEO (France)
  • 15:10 - 15:20
    Forendo Pharma Ltd, Maarit Merla, Head of Business Development (Finland)
  • 15:20 - 15:30
    Oxstem, Michael Stein, CEO (United Kingdom)

Early Stage Showcase - Medtech
Tuesday, 9th May - 13:30 to 15:30
Chaired By:
Companies:

  • 13:30 - 13:40
    Oxford Endovascular Ltd, Mike Karim, CEO (United Kingdom)
  • 14:00 - 14:10
    InspiWave, Phi Phan, Founder (United Kingdom)
  • 14:10 - 14:20
    Oxford Cardiomox, Ji Wenming, CEO

Early Stage Showcase - Platform Technology
Tuesday, 9th May - 13:30 to 15:30
Chaired By:
Companies:

  • 13:30 - 13:40
    Blueberry Therapeutics , Mike Davies, Chief Medical Officer (United Kingdom)
  • 13:40 - 13:50
    PeptiGelDesign, Guillaume Saint-Pierre, CEO (United Kingdon)
  • 13:50 - 14:00
    Sibelius, Peter Leyland, CEO (United Kingdon)
  • 14:00 - 14:10
    Lycotec, Ivan Petyaev, CEO (UK)
  • 14:10 - 14:20
    Liverpool ChiroChem Ltd, Paul Colbon, Founder and CEO (United Kingdon)
  • 14:20 - 14:30
    Nanogenic Solutions , Jonathan Lane, CEO (UK)

Later Stage Showcase - Biotech 1
Tuesday, 9th May - 15:30 to 16:30
Chaired By:
Companies:

  • 15:30 - 15:45
    Mereo BioPharma Group plc, Denise Scots-Knight, CEO (United Kingdom)
  • 15:45 - 16:00
    Sanifit, Joan Perelló , CEO and Co-Founder (Spain)
  • 16:00 - 16:15
    Cell Medica, Gregg Sando, CEO (United Kingdon)

Later Stage Showcase - Pharma
Tuesday, 9th May - 15:30 to 16:30
Chaired By:
Companies:

  • 15:30 - 15:45
    NeRRe Therapeutics, Mary Kerr, CEO (United Kingdom)
  • 15:45 - 16:00
    BerGenBio, Richard Godfrey, CEO (Norway)
  • 16:00 - 16:15
    Debiopharm International SA, Sandya Von Der Weid, Partnering Manager Europe & Asia (CH)
  • 16:15 - 16:30
    Galecto Biotech, Hans Schambye, CEO (Denmark)

Later Stage Showcase - Pharma 2
Tuesday, 9th May - 15:30 to 16:30
Chaired By:
Companies:

  • 15:30 - 15:45
    Addex Therapeutics , Tim Dyer, CEO (Switzerland)

Early Stage Showcase - Biotech Therapeutics
Wednesday, 10th May - 10:10 to 11:10
Chaired By:
Companies:

  • 10:10 - 10:20
    Acousia Therapeutics GmbH, Christoph Antz, CEO (Germany)
  • 10:20 - 10:30
    Junction Therapeutics, Clyde Hutchinson, CEO (Ireland)
  • 10:30 - 10:40
    NeuroVive Pharmaceutical AB, Erik Kinnman, CEO (Sweden)
  • 10:40 - 10:50
    Amal Therapeutics , Madiha Derouazi , CEO
  • 10:50 - 11:00
    Oblita Therapeutics BVBA, Caroline Jansen, Managing Director (Belgium)

Contact us

To discuss Company Showcases, Later Stage Showcases and Perfect Pitch opportunities contact:

Mark Hooper, Head of Sales 
Email: Mark.Hooper@obn.org.uk or tel: +44 (0) 1235 420874 or +44 (0) 7795 688604

Jonathan Rohll, Analyst and EU Project Manager
Email:  jonathan.rohll@obn.org.uk or tel: +44 (0)1235 420 877